Anivance AI Corporation
Anivance AI combines organ chips with Multi-Agent AI. With 35 patents and global collaborations, we deliver plug-and-play platforms and LaaS services, supporting rare disease and inhalation models, diverse preclinical studies, and predictive, clinically-relevant data for accelerated drug discovery.
STEMCELL Technologies
We are the world-leading provider of reagents and services for generating organoid and stem cell-derived models of healthy and diseased human tissues.
CN Bio
CN Bio is a leading bioengineering company specializing in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of tomorrow’s medicines.